Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -76.63%-77.94M | -3.33%-81.11M | -22.80%-55.41M | -177.08%-133.79M | -127.10%-44.12M | -144.68%-78.5M | -134.18%-45.12M | -65.01%173.58M | -41.72%162.82M | -0.61%175.68M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 43.60%-30.91M | 43.60%-30.91M | ---- | -66.22%-101.97M | -115.60%-54.81M | -115.60%-54.81M | ---- | -127.68%-61.35M | -178.89%-25.42M | -178.89%-25.42M |
| Attributable subsidiary (profit) loss | 20.71%-3.09M | 55.69%-1.24M | 53.79%-652K | 62.52%-3.46M | -85.86%-3.89M | 19.95%-2.81M | 7.17%-1.41M | 24.16%-9.23M | 56.91%-2.09M | -52.41%-3.5M |
| Impairment and provisions: | 358.45%1.13M | 358.45%1.13M | ---- | -97.47%91K | -237.30%-438K | -237.30%-438K | ---- | -82.42%3.6M | -94.80%319K | -94.80%319K |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 188.58%2.48M | ---- | ---- |
| -Impairment of trade receivables (reversal) | 358.45%1.13M | 358.45%1.13M | ---- | -91.88%91K | -237.30%-438K | -237.30%-438K | ---- | 7,100.00%1.12M | 353.17%319K | 353.17%319K |
| Revaluation surplus: | ---- | ---- | ---- | 137.86%39K | ---- | ---- | ---- | -32.05%-103K | ---- | ---- |
| -Fair value of investment properties (increase) | ---- | ---- | ---- | 137.86%39K | ---- | ---- | ---- | -32.05%-103K | ---- | ---- |
| Asset sale loss (gain): | -71.43%12K | -71.43%12K | ---- | -6.80%192K | 162.50%42K | 162.50%42K | ---- | 4,220.00%206K | 159.26%16K | 159.26%16K |
| -Loss (gain) on sale of property, machinery and equipment | -71.43%12K | -71.43%12K | ---- | -6.80%192K | 162.50%42K | 162.50%42K | ---- | 4,220.00%206K | 159.26%16K | 159.26%16K |
| Depreciation and amortization: | 30.36%539.05M | 30.30%351.78M | 29.33%172.13M | 11.07%555.83M | 11.37%413.53M | 10.64%269.97M | 10.60%133.09M | 9.54%500.44M | 6.39%371.3M | 4.91%244M |
| -Depreciation | 30.45%187.27M | ---- | 29.33%172.13M | ---- | 12.77%143.56M | ---- | 10.60%133.09M | ---- | 9.34%127.31M | ---- |
| -Amortization of intangible assets | -42.05%4.79M | -42.05%4.79M | ---- | 29.26%15.96M | 41.74%8.27M | 41.74%8.27M | ---- | 11.23%12.35M | 6.77%5.84M | 6.77%5.84M |
| Financial expense | -15.94%41.55M | -15.94%41.55M | ---- | -3.37%97.11M | -12.82%49.43M | -12.82%49.43M | ---- | 149.18%100.5M | 278.50%56.7M | 278.50%56.7M |
| Special items | ---- | ---- | ---- | -97.89%18K | -92.14%11K | -92.14%11K | ---- | -30.42%853K | -86.23%140K | -86.23%140K |
| Adjustment items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --113.27M | ---- | ---- |
| Operating profit before the change of operating capital | 30.59%469.81M | 53.75%281.21M | 34.09%116.07M | -49.61%414.07M | -36.19%359.75M | -59.17%182.91M | -65.49%86.56M | -15.78%821.76M | -11.47%563.79M | 6.56%447.93M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -261.90%-46.37M | -261.90%-46.37M | ---- | 82.28%-17.31M | -129.60%-12.81M | -129.60%-12.81M | ---- | 36.82%-97.71M | 205.46%43.29M | 205.46%43.29M |
| Developing property (increase)decrease | 100.86%244K | 100.86%244K | ---- | 11.25%-39.15M | -216.42%-28.32M | -216.42%-28.32M | ---- | -48.88%-44.11M | 49.01%-8.95M | 49.01%-8.95M |
| Accounts receivable (increase)decrease | 12,034.67%8.95M | 12,034.67%8.95M | ---- | -92.48%1.04M | 99.67%-75K | 99.67%-75K | ---- | 111.88%13.87M | 66.33%-22.91M | 66.33%-22.91M |
| Accounts payable increase (decrease) | -92.49%6.09M | -92.49%6.09M | ---- | 238.67%139.11M | 173.75%81.13M | 173.75%81.13M | ---- | -165.93%-100.31M | -162.43%-110M | -162.43%-110M |
| prepayments (increase)decrease | 90.17%-3.18M | 90.17%-3.18M | ---- | -39.00%7.23M | -289.58%-32.39M | -289.58%-32.39M | ---- | 378.98%11.85M | 203.66%17.08M | 203.66%17.08M |
| Special items for working capital changes | 97.73%-4.53M | -101.73%-76K | ---- | 320.15%11.94M | -680.00%-199.3M | 334.06%4.38M | ---- | 73.87%-5.43M | 165.31%34.36M | -135.53%-1.87M |
| Cash from business operations | 156.58%431.01M | 26.71%246.86M | 34.09%116.07M | -27.52%516.93M | -67.49%167.98M | -46.56%194.82M | -65.49%86.56M | -11.05%713.2M | -16.30%516.65M | -20.52%364.56M |
| Other taxs | 52.78%-27.05M | 52.78%-27.05M | ---- | 19.67%-57.44M | 19.90%-57.27M | 19.90%-57.27M | ---- | -40.48%-71.51M | -40.61%-71.51M | -40.61%-71.51M |
| Special items of business | ---- | ---- | -43.53%-65.88M | ---- | ---- | ---- | 61.41%-45.9M | ---113.27M | ---- | ---- |
| Adjustment items of business operations | ---- | ---- | ---18K | ---- | ---- | ---- | ---- | --113.27M | ---- | ---- |
| Net cash from operations | 264.88%403.97M | 59.81%219.82M | 23.38%50.17M | -28.39%459.5M | -75.13%110.71M | -53.06%137.55M | -69.17%40.66M | -14.54%641.7M | -21.41%445.15M | -28.15%293.06M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -21.90%35.92M | -21.90%35.92M | ---- | 33.28%82.03M | 66.35%45.99M | 66.35%45.99M | ---- | 116.35%61.55M | 505.08%27.65M | 505.08%27.65M |
| Sale of fixed assets | -82.41%19K | -82.41%19K | ---- | 115.38%112K | 980.00%108K | 980.00%108K | ---- | -52.29%52K | --10K | --10K |
| Purchase of fixed assets | 4.30%-1.18B | -83.94%-918.58M | -68.84%-510.85M | -206.62%-2.78B | -114.43%-1.23B | -30.88%-499.4M | -39.68%-302.57M | 8.99%-906.61M | 13.51%-575.24M | -61.39%-381.59M |
| Acquisition of subsidiaries | ---2.79M | ---2.79M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | --2.65M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | 20.37%-14.03M | ---- | ---- | ---17.62M | ---17.62M | ---17.62M | ---- | ---- | ---- | ---- |
| Other items in the investment business | 55.48%28.22M | --5.59M | 357.08%16.56M | 251.94%41.15M | 12.13%18.15M | ---- | -72.84%3.62M | -69.56%11.69M | -51.72%16.19M | ---- |
| Net cash from investment operations | 4.52%-1.13B | -86.83%-879.85M | -65.34%-494.29M | -220.59%-2.67B | -123.34%-1.19B | -33.06%-470.92M | -47.06%-298.95M | 10.41%-833.31M | 15.25%-531.4M | -55.88%-353.93M |
| Net cash before financing | 32.24%-729.18M | -97.99%-660.03M | -71.95%-444.12M | -1,054.41%-2.21B | -1,147.73%-1.08B | -447.66%-333.37M | -261.69%-258.29M | -6.87%-191.62M | -42.39%-86.25M | -133.67%-60.87M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 436.80%1.1B | 393.50%999.08M | 732.63%860.99M | -52.99%289.29M | -44.49%204.73M | 860.01%202.45M | 697.14%103.41M | 19.59%615.42M | 10.70%368.8M | -75.01%21.09M |
| Refund | -921.80%-940.12M | -970.30%-936.83M | ---811.16M | 56.52%-183.52M | 74.94%-92.01M | 31.67%-87.53M | ---- | -111.41%-422.12M | -129.71%-367.18M | -31.14%-128.09M |
| Issuing shares | 1,271.12%29.67M | 2,107.07%15.3M | 11,371.05%13.08M | -99.88%3.64M | -99.93%2.16M | -75.68%693K | -92.09%114K | 46,986.19%2.94B | 63,589.37%2.94B | 73.19%2.85M |
| Interest paid - financing | 15.19%-46.85M | 19.40%-41.88M | -50.90%-3.25M | 0.78%-105.74M | 9.94%-55.24M | 9.70%-51.96M | 43.73%-2.16M | -125.37%-106.57M | -299.95%-61.34M | -317.39%-57.53M |
| Dividends paid - financing | ---- | ---- | ---- | ---36.25M | ---28.88M | ---28.88M | ---- | ---- | ---- | ---- |
| Absorb investment income | ---- | ---- | ---- | 50.00%1.18B | 299.02%1.18B | 299.02%1.18B | 132.76%689.43M | 101.00%787.92M | -24.44%296.2M | --296.2M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -143.99%-2.03M | ---612K | ---612K |
| Pledged bank deposit (increase) decrease | ---- | ---- | ---- | ---- | 76.39%-7.37M | 95.61%-7.37M | ---- | -4,012.52%-31.21M | ---31.21M | ---167.74M |
| Other items of the financing business | ---- | ---- | ---- | 82.15%5.46M | ---- | ---- | ---- | -73.00%3M | ---1.42M | ---- |
| Net cash from financing operations | -88.50%138.12M | -97.18%33.95M | -92.51%59.14M | -69.59%1.15B | -61.74%1.2B | 3,365.45%1.21B | 200.06%789.91M | 462.61%3.78B | 468.70%3.14B | -33.59%-36.93M |
| Effect of rate | -35.28%36.66M | 140.72%13.85M | 165.45%5.77M | -367.71%-64.14M | 178.17%56.65M | 43.33%-34M | -149.13%-8.82M | 85.45%-13.71M | 38.26%-72.47M | -7.86%-60M |
| Other items affecting net cash | ---- | ---- | --18K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net Cash | -573.14%-591.06M | -171.74%-626.08M | -172.41%-384.97M | -129.58%-1.06B | -95.91%124.92M | 992.26%872.69M | 177.12%531.62M | 628.39%3.59B | 521.24%3.05B | -163.87%-97.81M |
| Begining period cash | -20.16%4.46B | -20.16%4.46B | -20.16%4.46B | 178.04%5.59B | 178.04%5.59B | 178.04%5.59B | 178.04%5.59B | 24.76%2.01B | 24.76%2.01B | 24.76%2.01B |
| Cash at the end | -32.29%3.9B | -40.12%3.85B | -33.20%4.08B | -20.16%4.46B | 15.58%5.77B | 247.06%6.42B | 175.31%6.11B | 178.04%5.59B | 151.46%4.99B | 8.39%1.85B |
| Cash balance analysis | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Accounting Firm | -- | -- | -- | Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.